Europlasma SA (FR:ALEUP) has released an update.
Europlasma SA reports a revenue increase of 6.1% to €15.4M in 2023 despite operational challenges, including supplier delays and high energy costs. The company’s EBITDA declined, registering a controlled fall to -€13.0M, with a net result improvement of €1.2M over the previous year. Looking ahead, Europlasma expresses confidence for 2024, buoyed by a supportive commercial environment and a focus on enhancing production profitability.
For further insights into FR:ALEUP stock, check out TipRanks’ Stock Analysis page.
